{"text": "JOHANNESBURG Aspen Pharmacare plans to start supplying Johnson & Johnson COVID-19 vaccine doses from its facility in South Africa before the end of June, its chief executive said on Friday.Stephen Saad told Reuters in an interview that the technology transfer from J&J has gone very well and we are now committing commercial supply in our financial year.The companys financial year ends in June.The company has committed 300 million COVID-19 vaccine doses, however the final amount that will be manufactured will depend on demand from J&J, he said."}